FindTrial
Sign In

Application of Biplanar Stereotactic Biopsy in the Diagnosis of Localized Prostate Cancer: A Single-Center Retrospective Study

Application of Biplanar Stereotactic Biopsy in the Diagnosis of Localized Prostate Cancer: A Single-Center Retrospective Study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400087842
Enrollment
Unknown
Registered
2024-08-05
Start date
2024-08-26
Completion date
Unknown
Last updated
2024-08-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Prostate Cancer

Interventions

Biplanar group:None
Mono-planar group:None

Sponsors

Shanghai General Hospital
Lead Sponsor

Eligibility

Sex/Gender
Male
Age
25 Years to 90 Years

Inclusion criteria

Inclusion criteria: 1.Patients with suspected prostate cancer having a PSA > 4.0 ng/mL. 2.Detection of a harder nodule in digital rectal examination. 3.Abnormal imaging findings with a PI-RADS score > 2. 4.Complete medical records.

Exclusion criteria

Exclusion criteria: 1.History of surgery for benign prostatic hyperplasia. 2.Repeat transrectal biopsy. 3.Coexisting cardiac or pulmonary dysfunction. 4.Severe bleeding tendency. 5.Poor control of underlying diseases such as hypertension or diabetes. 6.Missing or incomplete data. 7.Errors in clinical procedures leading to misdiagnosis.

Design outcomes

Primary

MeasureTime frame
PSA;Prostate volume;Age;Number of positive needles ;Gleason score ;—

Countries

China

Contacts

Public ContactYuan Ruan

Shanghai General Hospital

yuanraun@sjtu.edu.cn+86 21 3379 8596

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026